Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Centronuclear Myopathy - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering. The report provides comprehensive ...
DelveInsight’s, “Obesity - Pipeline Insight, 2025” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Obesity pipeline landscape. It covers the pipeline drug ...
RYR1 mutations have been mainly implicated in CNM2 associated with autosomal-recessive inheritance. 3, 4 Implication of heterozygous RYR1 mutations in dominant CNM awaits confirmation. MTMR14/hJUMPY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results